Purchase Order 75N91022P00715

The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $265,200 purchase order to Illumina, Inc. to deliver one NextSeq 2000 sequencing system, a one-year DRAGEN software license, and installation services. The sequencing system and software will replace aging equipment and reduce costs while enabling continued use of validated protocols to support the Center for Cellular Engineering's research efforts. The single award was made on a non-competitive...

This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA) to 10X Genomics, Inc., a life sciences technology company, for a single cell sequencer. The contract award, valued at $95,100.00, is not associated with a set-aside designation. The sequencer will be used to support NIA's Center for Alzheimer's Disease and Related Dementias, which is planning a large project to perform single-cell RNA sequencing on 200 induced pluripotent stem cell lines differentiated...

The U.S. Defense Health Agency awarded a firm fixed-price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents, to provide a NextSeq 550 Sequencing System and related consumables. This sole-source acquisition was made under FAR Part 12 for commercial items, as the Armed Forces DNA Identification Laboratory (AFDIL) had validated Illumina's NextSeq platform as the only technically acceptable equipment to support their increased...

The Department of Health and Human Services National Institutes of Health (NIH) awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the supply of an Illumina NextSeq2000 DNA sequencer. The $239,700 contract is intended to support the sequencing and genomic analysis work of the NIH's National Institute on Deafness and Other Communication Disorders (NIDCD) Genomics and Computational Biology Core. The award was...

Seqmatic, LLC has been awarded a $32,485 firm fixed price purchase order by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to provide single nuclei RNA sequencing sample testing services. As a minority-owned and Asian-Pacific American owned small business, Seqmatic will leverage over 10 years of experience in next generation sequencing, single cell analysis, library preparation, and bioinformatics to deliver the...

This is a federal contract award to Seqgen, Inc., a Torrance, California-based provider of scientific instruments and lab equipment, including genetic analyzers and sequencers. The contract, valued at $86,300.00, was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the National Institutes of Health (NIH). The contract is for the provision of genomic sequencing systems and services, and does not have a set-aside designation....

This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a part of the National Institutes of Health (NIH), to Singulomics Corp, a biotechnology company specializing in single cell omics research and services. The $27,893 contract is for DNA single cell sequencing of mouse tissue specimens to support NIA's research on Alzheimer's disease and related dementias. The period of performance is from July 19, 2021 to December 1, 2021. This contract was not set aside...

The Department of Health and Human Services National Institutes of Health National Institute on Alcohol Abuse and Alcoholism awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing equipment and consumables, to provide a NextSeq 2000 Sequencing System and associated services for $248,675.00. The contract has no set-aside designation. This purchase order was issued under a sole source solicitation, as the NextSeq 2000 system is the only platform...

This $340,025 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Illumina, Inc. to deliver an Illumina NextSeq 2000 Sequencer or equivalent high-throughput next-generation sequencing system. The solicitation sought quotes for this sequencing equipment to increase NIAID's capacity for sequencing samples related to...

This $438,600 firm fixed price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc. to deliver a SEQUEL IIE SYSTEM long-read DNA/RNA sequencing machine. The solicitation sought quotes for a turnkey sequencing solution to detect pathogen variants, access previously inaccessible genomic regions, and advance genetic research at the FDA's Center for Biologics Evaluation and Research Division of Cell and Gene...